Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
RSV (Respiratory syncytial virus)
Older adults
Europe
Western Pacific
Clear all
Type of publications
NITAG documentation
(4)
Systematic reviews (SYSVAC)
(12)
Topics
Available to download in languages
Regions
Europe
(8)
Western Pacific
(8)
Africa
(4)
Americas
(8)
Eastern Mediterranean
(2)
South-East Asia
(2)
Countries
Australia
(1)
Belgium
(1)
China
(7)
Ireland
(1)
Italy
(1)
United Kingdom
(5)
Diseases
COVID-19
(14)
RSV (Respiratory syncytial virus)
(2)
Hepatitis A
(1)
Hepatitis B
(2)
Herpes zoster
(1)
Human papillomavirus (HPV)
(2)
Influenza
(3)
Measles
(1)
Meningococcal disease
(1)
Mumps
(1)
Pneumococcal disease
(3)
Rubella
(1)
Vaccine topics
Acceptance
(1)
Coverage
(1)
Economic aspects
(1)
Efficacy/effectiveness
(2)
Ethical issues
(2)
Safety
(1)
Target population
Older adults
(16)
Adolescents
(6)
Adults
(19)
All age groups
(28)
Children
(10)
Healthcare workers
(8)
Newborn
(3)
Parents/caregivers
(5)
Pregnant women
(2)
Risk group
(2)
Travellers
(2)
Publication date
2023
(5)
2022
(3)
2021
(3)
2020
(5)
16 results found
2021
∙
ATAGI
ATAGI statement on AstraZeneca vaccine in response to new vaccine safety concerns - 8 April, 2021
2020
∙
Parveen, R. Sehar, N. Bajpai, R. Bharal Agarwal, N.
Association of diabetes and hypertension with disease severity in covid-19 patients: a systematic literature review and exploratory meta-analysis
2020
∙
Zhang, J. Wu, J. Sun, X. Xue, H. Shao, J. Cai, W. Jing, Y. Yue, M. Dong, C.
Associations of hypertension with the severity and fatality of SARS-CoV-2 infection: A meta-analysis
2020
∙
Li, J. He, X. Yuanyuan, Zhang, W. Li, X. Zhang, Y. Li, S. Guan, C. Gao, Z. Dong, G.
Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia
2020
∙
Zhao, J. Li, X. Gao, Y. Huang, W.
Risk factors for the exacerbation of patients with 2019 novel coronavirus: A meta-analysis
2020
∙
JCVI
Advice on priority groups for COVID-19 vaccination
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register